Media & Events

Austria's Leading Companies (ALC) Awards: Winner's video

Marinomed Biotech AG is the winner of the "Research and Development" category

Vienna Stock Exchange Award 2021

June 18, 2021

The awarding of the Vienna Stock Exchange Prize - the most important award on the Austrian capital market - also took place in an exclusive setting in 2021. Marinomed won 3rd place in the "Mid-Cap" category. More information can be found here.

Austria’s Leading Companies (ALC) Award

For the 22nd time, the newspaper „Presse“, KSV1870 and PwC Austria awarded companies that make a lasting contribution to Austria's economy and location. Marinomed is the winner of the ALC Award in the category Research & Development. Find the whole article here. A clip of the award ceremony including a short interview with our CEO Andreas Grassauer (Min. 2:51) can be seen here.

KSV1870-CFO Hannes Frech (l.) congratulates Marinomed-CEO Andreas Grassauer (© Guenther Peroutka; Source: https://www.diepresse.com/5995131/alc-osterreich-die-sieger#slide-16)

Servus TV: "Servus am Abend" clip about Carragelose (German only)

April 28, 2021

ServusTV reported on Marinomed and the proven virus protection Carragelose. Carragelose is known as a well-tolerated, effective and safe means for the prevention and treatment of respiratory diseases. Increasingly, clinical data indicate that Carragelose also inactivates SARS-CoV-2. See the clip here.

ORF program "Konkret" about Carragelose (German only)

Austrian Stock Talk 2021

CEO Andreas Grassauer talks about the company and presents recent figures and facts.

Interview with life-science Austria

The nasal spray against SARS-CoV-2 - Interview with Eva Prieschl-Grassauer (CSO) and Andreas Grassauer (CEO)

Find more information here (German only): https://life-science.eu/nasenspray-und-pastillen-wirken-gegen-sars-cov-2/

BioMarine Interview

BioMarine interviews CSO Eva Prieschl-Grassauer on Carragelose

Fighting autoimmune gastritis

November 2020

In cooperation with the Medical University of Vienna, Marinomed is developing a treatment for autoimmune gastritis. Read the article in the magazine Chemiereport (2020/7) or in their ePaper. (German only)

Interview with the magazine BÖRSIANER

October 2020

Eva Prieschl-Grassauer and Andreas Grassauer talk about SARS-CoV-2 and their assessment of a vaccination against the virus, as well as Marinomed and the history of Carragelose. You can find the interview in the 40th issue of the magazine and here (German only).

Interview with the magazine TREND

August 2020

Eva Prieschl-Grassauer and Andreas Grassauer talk about the Coronavirus, Carragelose and the future of Marinomed (issue 33/2020). Read the full article here (German only).